Effects on blood lipid and androgen levels of two triphasic oral contraceptives.
Janaud
A
A
Hôpital Saint-Louis, Paris, France.
Rouffy
J
J
Upmalis
D
D
Dain
M P
MP
D000328:Adult; D000728:Androgens / Q000097:blood*; D001053:Apolipoproteins / Q000032:analysis; D002784:Cholesterol / Q000097:blood; D003277:Contraceptives, Oral, Combined / Q000494:pharmacology; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D009644:Norgestrel / Q000031:analogs & derivatives* / Q000494:pharmacology*; D012738:Sex Hormone-Binding Globulin / Q000032:analysis; D013739:Testosterone / Q000097:blood; D014280:Triglycerides / Q000097:blood
D000728:Androgens; D001053:Apolipoproteins; D003277:Contraceptives, Oral, Combined; D003280:Contraceptives, Oral, Synthetic; D004338:Drug Combinations; D008055:Lipids; D012738:Sex Hormone-Binding Globulin; D014280:Triglycerides; C109079:norgestimate, ethinyl estradiol drug combination; D009644:Norgestrel; D013739:Testosterone; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; D002784:Cholesterol